Inflammation's role in rectal cancer following prostate radiotherapy, and emerging evidence for a protective role for balsalazide

Gastroenterology. 2005 Aug;129(2):770-2. doi: 10.1016/j.gastro.2005.06.042.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Aminosalicylic Acids / therapeutic use*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Humans
  • Male
  • Mesalamine
  • Neoplasms, Radiation-Induced / prevention & control*
  • Phenylhydrazines
  • Primary Prevention / methods
  • Prognosis
  • Prostatic Neoplasms / diagnosis
  • Prostatic Neoplasms / radiotherapy*
  • Radiation Injuries / prevention & control
  • Rectal Neoplasms / etiology
  • Rectal Neoplasms / prevention & control*
  • Risk Assessment
  • Treatment Outcome

Substances

  • Aminosalicylic Acids
  • Phenylhydrazines
  • Mesalamine
  • balsalazide